Perpetual Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$17.8M Buy
229,286
+36,644
+19% +$2.97M 2.13% 11
2022
Q3
$15.6M Buy
192,642
+17,546
+10% +$1.58M 2.27% 10
2022
Q2
$15.7M Buy
175,096
+51,488
+42% +$5.22M 2.3% 11
2022
Q1
$13.7M Buy
123,608
+115,171
+1,365% +$12.2M 1.72% 13
2021
Q4
$873K Buy
8,437
+1,651
+24% +$191K 0.1% 141
2021
Q3
$850K Sell
6,786
-59,152
-90% -$7.66M 0.11% 136
2021
Q2
$8.19M Buy
65,938
+465
+0.7% +$58.4K 1.16% 26
2021
Q1
$7.71M Sell
65,473
-92
-0.1% -$10.8K 1.28% 29
2020
Q4
$7.58M Buy
+65,565
New +$7.22M 1.12% 29

Other funds holding MDT

Perpetual Investment Management's MDT Position: Q4 2022 in Review

Perpetual Investment Management increased its Medtronic (MDT) stake by 19% in Q4 2022, buying an estimated $2.97M and bringing the position to 229,286 shares worth $17.8M. The position accounts for 2.13% of the portfolio, ranked #11.

Perpetual Investment Management first reported a position in MDT in Q4 2020 and has held it in 9 quarters since. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Perpetual Investment Management held 229,286 shares of Medtronic worth $17.8M as of Q4 2022.
  • Perpetual Investment Management bought 36,644 Medtronic shares in Q4 2022, an estimated $2.97M.
  • Medtronic made up 2.13% of Perpetual Investment Management's portfolio in Q4 2022, its #11 holding.
  • Perpetual Investment Management first reported a position in Medtronic in Q4 2020 and has held it in 9 quarters since.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Perpetual Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.